Annexin V-FITC/PI Apoptosis Kit
中文名称：Annexin V-FITC / PI细胞凋亡检测试剂盒
Price:
- 应用： 细胞凋亡-Annexin V
| 检测原理 | Annexin V是一种钙离子依赖性磷脂结合蛋白，与磷脂酰丝氨酸PS有高度亲和力，可通过细胞外侧暴露的PS与凋亡早期细胞胞膜结合，将Annexin V标记荧光染料，利用流式细胞仪检测细胞凋亡。
细胞核染料（PI,DAPI,7-AAD）可与双链DNA特异性结合，并产生强烈的荧光，正常情况下无法透过细胞膜。由于凋亡晚期或坏死细胞膜丧失完整性，细胞核染料（DAPI、PI、7-AAD）可进入细胞内对DNA进行染色，与Annexin V搭配使用，可区分处于不同凋亡时期的细胞。 |
| 检测方法 | 荧光法;流式 |
| 样本类型 | 细胞 |
| 检测时间 | 40 min |
| 检测仪器 | 流式细胞仪 |
| 荧光 | FITC |
| Ex/Em | 490/530 |
| Channel set | FITC |
| 自备试剂 | PBS(E-BC-R187), 去离子水 |
| 保存温度 | 该产品可在 2~8°C避光条件下保存12个月。 |
| 有效期 | 12个月 |
| 运输条件 | 冰袋 |
-
Gene expression profiling and in vitro functional studies reveal RAD54L as a potential therapeutic target in multiple myeloma
IF: 2.164 -
Curcumin improves atherosclerosis by inhibiting the epigenetic repression of lncRNA MIAT to miR-124
IF: 1.105 -
New fluorobenzamidine exerts antitumor activity against breast cancer in mice via pro-apoptotic activity
Journal： Discover Oncology (2022) -
Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma
IF: 13.273Journal： CHEMICAL ENGINEERING JOURNAL (2021) -
Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer
IF: 7.348 -
NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway
IF: 6.684Journal： Frontiers in Cell and Developmental Biology (2021)PMID：34277602 -
Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma
IF: 6.498Journal： Translational Lung Cancer Research (2021)PMID：33718039Reactivity：HumanSample Type：Cell sample(A549/TaxR cells,A549 cells) -
Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment
IF: 6.321 -
Discovering and Characterizing of Survivin Dominant Negative Mutants With Stronger Pro-apoptotic Activity on Cancer Cells and CSCs
IF: 6.244 -
COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
IF: 6.244Journal： Frontiers in Oncology (2021)
| E-CK-A111 | Annexin V-FITC Reagent | 500 Tests , 200 Tests , 100 Tests , 50 Tests |
| E-CK-A151 | Annexin V Binding Buffer (10×) | 50 mL , 10 mL |
| E-CK-A212 | Annexin V-FITC/7-AAD Apoptosis Kit | 200 Assays , 100 Assays , 50 Assays , 20 Assays |
| E-CK-A252 | Annexin V-FITC/DAPI Apoptosis Kit | 200 Assays , 100 Assays , 50 Assays , 20 Assays |
| E-CK-A301 | Mitochondrial Membrane Potential Assay Kit (with JC-1) | 100 Assays , 50 Assays , 20 Assays |
| E-CK-A320 | One-step TUNEL In Situ Apoptosis Kit (Green, FITC) | 100 Assays , 50 Assays , 20 Assays |
